$DOCUNeutralMed

DocuSign Delivers Beat-And-Raise Q1, But Investors Aren't Impressed - Docusign (NASDAQ:DOCU)

DocuSign reported Q1 revenue of $830.2 million, slightly above the $824.77 million consensus, and adjusted EPS of $1.09 versus $0.99 expected, according to Benzinga Pro. Revenue rose 9% YoY; free cash flow was $289.4 million. The company repurchased $317.5 million of stock and raised FY revenue guidance to $3.49–$3.502 billion. Shares were down 4.02% after hours to $48.85.

9/10
7/10
Med
Neutral
after-hours reaction; earnings call at 5 p.m. ET
Mixed—fundamentals beat/raise, but market sold the news

Beat-and-raise plus raised FY revenue guidance, but shares fell ~4% after hours, implying investors discounted the quality/trajectory of growth or margins.

DocuSign reported Q1 revenue and EPS beats, raised full-year guidance, and guided Q2 revenue—driving the stock’s after-hours move.

Near-term volatility likely persists into the earnings call as traders reprice the guidance and AI/IAM demand narrative.

Background

DocuSign is an agreement management platform provider; this article is a post-earnings recap highlighting Q1 performance, AI-native IAM customer growth, and updated revenue guidance.

Why it matters

The key tradable inputs are the Q2 revenue range and the raised full-year revenue guidance, alongside the reported after-hours decline despite the beat-and-raise.

Market relevance

Beat-and-raise with raised FY guidance, yet the stock fell after hours—suggesting expectations or forward-looking quality concerns remain the market’s focus.

Market effects

Signals continued demand for e-signature/contract workflow software and AI-native identity/access management, but also highlights that valuation expectations can overpower fundamentals.

Primarily US software/enterprise SaaS sentiment; limited direct regional spillover beyond US growth stocks.

Moderate—enterprise workflow and IAM demand is global, but the catalyst is company-specific guidance and results.

Alternative perspectives

The after-hours drop may be an overreaction to guidance optics; the raised FY range and strong free cash flow/share buybacks could support a rebound if management clarifies demand durability.

Investors may be focusing on the gap between Q2 guidance and consensus (even if close), plus any implied margin/expense trajectory not detailed in the article; AI customer growth (40,000) may not translate immediately into revenue acceleration.

Key entities

  • DocuSign

    Reported Q1 revenue/EPS beats, guided Q2 revenue, raised FY revenue guidance, and repurchased $317.5M of stock.

Related articles

$LULUMed

Stock Market Today: Dow Futures Gain, S&P 500 Slips As Trump Floats Meeting Iran's Supreme Leader— Lulule

U.S. stock futures were mixed Friday: Nasdaq 100 and S&P 500 slipped while Dow futures rose after a mixed prior close. President Trump said he would consider meeting Iran’s Supreme Leader Ayatollah Mojtaba Khamenei if diplomacy progresses. Treasury yields were 4.46% (10-year) and 4.03% (2-year); FedWatch priced a 96.4% chance of no June rate change. Lululemon, Docusign (-4.73%), Samsara (-5.14%), and Keel (-8.94% on $350m convertibles) were among movers.

$LULUHighAI 9/10

Stocks making the biggest moves after hours: Lululemon Athletica, ServiceTitan, Argan and more

After-hours movers: Lululemon shares fell 10% after it cut full-year earnings and revenue guidance and its current-quarter outlook missed analyst expectations, per LSEG. Docusign slipped 4% as its Q2 revenue outlook ($865M–$869M) met but didn’t beat estimates. Guidewire dropped 16% on weaker adjusted gross margin. ServiceTitan rose 12% after raising full-year guidance.

$DOCUMedAI 9/10

DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For

DocuSign will report Q1 results Thursday after the bell, according to the article. The company’s prior quarter revenue was $836.9 million (+7.8% YoY), but it missed annual recurring revenue estimates. For Q1, analysts expect revenue +8.1% YoY. The article cites an average analyst price target of $59.88 vs. $55.18.

$DOCULowAI 9/10

Dear Docusign Stock Fans, Mark Your Calendars for June 4

DocuSign shares have fallen 36.58% over 52 weeks and 17.84% YTD, but rose 24.69% over three months and 17.18% in the past month, ahead of earnings. After Q4 FY2026 results on March 17, revenue rose 7.8% YoY to $836.9M (above $828.2M est.); non-GAAP EPS was $1.01 (vs $0.95). Billings exceeded $1B for the first time. Q1 FY2027 revenue guidance: $822M–$826M. Analysts rate DOCU “Hold” with $58.81 average target.